PTLF (Petlife Pharmaceuticals) Scaled Net Operating Assets: -20.33 (As of Feb. 2018)


What is Petlife Pharmaceuticals Scaled Net Operating Assets?

Petlife Pharmaceuticals PTLF Scaled Net Operating Assets is -20.33 as of Feb. 2018.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Petlife Pharmaceuticals's operating assets for the quarter that ended in Feb. 2018 was $0.00 Mil. Petlife Pharmaceuticals's operating liabilities for the quarter that ended in Feb. 2018 was $1.18 Mil. Petlife Pharmaceuticals's Total Assets for the quarter that ended in Nov. 2017 was $0.06 Mil. Therefore, Petlife Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2018 was -20.33.

Petlife Pharmaceuticals Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Scaled Net Operating Assets Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -21.53 -616.60 -718.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.62 -2.30 -2.66 -19.67 -20.33

PTLF vs PCYN, YBAO, BKIT: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Scaled Net Operating Assets falls into.


Petlife Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Petlife Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2017 is calculated as

Scaled Net Operating Assets (SNOA)(A: Aug. 2017 )
=(Operating Assets (A: Aug. 2017 )-Operating Liabilities (A: Aug. 2017 ))/Total Assets (A: Aug. 2016 )
=(0.001-0.719)/0.001
=-718.00

where

Operating Assets(A: Aug. 2017 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.055 - 0.054
=0.001

Operating Liabilities(A: Aug. 2017 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.436 - 0 - 0.717
=0.719

Petlife Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2018 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2018 )
=(Operating Assets (Q: Feb. 2018 )-Operating Liabilities (Q: Feb. 2018 ))/Total Assets (Q: Nov. 2017 )
=(0-1.179)/0.058
=-20.33

where

Operating Assets(Q: Feb. 2018 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.008 - 0.008
=0

Operating Liabilities(Q: Feb. 2018 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.981 - 0 - 0.802
=1.179

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -20.33 mean?
Petlife Pharmaceuticals (PTLF) has a Scaled Net Operating Assets of -20.33 as of Feb. 2018. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Scaled Net Operating Assets too high?
Petlife Pharmaceuticals' current Scaled Net Operating Assets is -20.33.
How does Petlife Pharmaceuticals' Scaled Net Operating Assets compare to PCYN and YBAO?
Petlife Pharmaceuticals' Scaled Net Operating Assets of -20.33 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Scaled Net Operating Assets is -20.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Scaled Net Operating Assets of -20.33. The current Scaled Net Operating Assets is -20.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Scaled Net Operating Assets is -20.33 as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.